Literature DB >> 22269658

Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.

Jammie Barnes1, Maureen D Mayes.   

Abstract

PURPOSE OF REVIEW: To identify the recent data regarding prevalence, incidence, survival, and risk factors for systemic sclerosis (SSc) and to compare these data to previously published findings. RECENT
FINDINGS: SSc disease occurrence data are now available for Argentina, Taiwan, and India and continue to show wide variation across geographic regions. The survival rate is negatively impacted by older age of onset, male sex, scleroderma renal crisis, pulmonary fibrosis, pulmonary arterial hypertension, cancer, and antitopoisomerase and anti-U1 antibodies. It appears that silica exposure confers an increased risk for developing scleroderma, but this exposure accounts for a very small proportion of male patients. Smoking is not associated with increased SSc susceptibility. Malignancies are reported in scleroderma at an increased rate, but the magnitude of this risk and the type of cancer vary among reports.
SUMMARY: Prevalence and incidence of SSc appears to be greater in populations of European ancestry and lower in Asian groups. Exposure to silica dust appears to be an environmental trigger, but this only accounts for a small proportion of male cases. Evidence for increased risk of neoplasia is suggestive, but the magnitude of the risk and the types of malignancies vary among reports.

Entities:  

Mesh:

Year:  2012        PMID: 22269658     DOI: 10.1097/BOR.0b013e32834ff2e8

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  82 in total

1.  Identification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing.

Authors:  Li Gao; Mary J Emond; Tin Louie; Chris Cheadle; Alan E Berger; Nicholas Rafaels; Candelaria Vergara; Yoonhee Kim; Margaret A Taub; Ingo Ruczinski; Stephen C Mathai; Stephen S Rich; Deborah A Nickerson; Laura K Hummers; Michael J Bamshad; Paul M Hassoun; Rasika A Mathias; Kathleen C Barnes
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

2.  [Calcinosis and scleroderma].

Authors:  Xavier Pujol Olivares
Journal:  Aten Primaria       Date:  2018-10-26       Impact factor: 1.137

3.  Anti-cytokine autoantibodies in autoimmune diseases.

Authors:  Giuseppe Cappellano; Elisabetta Orilieri; Abiy D Woldetsadik; Elena Boggio; Maria F Soluri; Cristoforo Comi; Daniele Sblattero; Annalisa Chiocchetti; Umberto Dianzani
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

4.  Shiny white patches of the arms and forehead.

Authors:  Jason Emer; Dean David George; Sebastian Bernardo; Harleen Sidhu
Journal:  J Clin Aesthet Dermatol       Date:  2013-08

Review 5.  The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Maria Clorinda Mazzarino
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

6.  Interstitial lung disease in South Africans with systemic sclerosis.

Authors:  Philippa Ashmore; Mohammed Tikly; Michelle Wong; Claudia Ickinger
Journal:  Rheumatol Int       Date:  2017-11-28       Impact factor: 2.631

7.  Kelch-like protein 42 is a profibrotic ubiquitin E3 ligase involved in systemic sclerosis.

Authors:  Travis B Lear; Karina C Lockwood; Mads Larsen; Ferhan Tuncer; Jason R Kennerdell; Christina Morse; Eleanor Valenzi; Tracy Tabib; Michael J Jurczak; Daniel J Kass; John W Evankovich; Toren Finkel; Robert Lafyatis; Yuan Liu; Bill B Chen
Journal:  J Biol Chem       Date:  2020-02-17       Impact factor: 5.157

Review 8.  Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis.

Authors:  Xiao-Lei Huang; Yu-Jie Wang; Jun-Wei Yan; Ya-Nan Wan; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Jing Wang
Journal:  Inflamm Res       Date:  2015-03-01       Impact factor: 4.575

9.  Identification of Cysteine-Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in Scleroderma.

Authors:  Pei-Suen Tsou; Dinesh Khanna; Amr H Sawalha
Journal:  Arthritis Rheumatol       Date:  2019-06-12       Impact factor: 10.995

10.  Measuring illness behavior in patients with systemic sclerosis.

Authors:  Erin L Merz; Vanessa L Malcarne; Scott C Roesch; Roozbeh Sharif; Brock E Harper; Hilda T Draeger; Emilio B Gonzalez; Deepthi K Nair; Terry A McNearney; Shervin Assassi; Maureen D Mayes
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.